In Simple Terms
A virus known mainly for infecting animals was linked to the death of a man in France who had a severely weakened immune system. There is no evidence that it is spreading from person to person or causing an outbreak. Scientists are now trying to find out how the man caught it and whether other infections have gone unnoticed.
An exceptional case, six decades after the virus was discovered
Shamonda virus was first identified in cattle in Nigeria in 1965, and for decades it was known mainly as an animal disease. The case in France is the first documented human infection—and the first known human death attributed to the virus. The medical report, published in the journal Eurosurveillance, brings Shamonda into the conversation as a possible human health risk. It does not, however, show that human infections are common.
The patient was a 61-year-old man receiving treatment for leukemia at a civilian hospital in Lyon. He had undergone a stem cell transplant, a treatment that can leave the immune system extremely weakened. He developed encephalitis, an inflammation of the brain, followed by neurological symptoms including blindness and confusion. The report’s authors believe the virus was responsible for his symptoms.
His condition later worsened, and he fell into a coma. On October 9, 2026, he died after life support was withdrawn. This single report cannot tell us what the virus might do to the wider population, but it shows that a rare infection can be extremely dangerous for someone with a severely weakened immune system. And although this is the first known death, that does not mean every infection with the virus would be fatal: the evidence from human cases remains extremely limited.
How did a cattle virus reach a person?
Early evidence points to tiny blood-feeding insects called biting midges, which belong to the genus Culicoides. France’s health and agriculture ministries suspect that the man was infected by an insect bite in the east of the country, where the virus has been detected in several animals. The findings from France have been reported to the World Health Organization and the European Centre for Disease Prevention and Control.
Researchers are still investigating how the virus reached the patient, and the available information offers no indication that he caught it from another person. Clinical virologist Gregory Destra, at a hospital in Lyon and one of the report’s authors, stresses that current evidence does not suggest Shamonda is becoming more widespread among people. He raises one possible explanation: the virus may have entered the man’s body weeks before his neurological symptoms began, then continued to multiply during a relatively long incubation period.
That possibility helps explain why it can be difficult to connect an unusual case of brain inflammation to a particular virus. There may be a gap between exposure to a possible carrier and the onset of illness, and the symptoms can resemble those of other diseases—especially in someone being treated for leukemia after a stem cell transplant. Finding one case is not enough to establish how the virus was transmitted or how likely similar infections are to occur.
An animal virus found in multiple species
Shamonda is not limited to cattle. It has also been identified in sheep, goats, horses and alpacas. The symptoms in animals vary and may include fever, diarrhea and reduced milk production. Although the virus can infect different species, it does not appear to spread readily among animals, and it is not usually fatal to adult animals. Pregnant animals face a particular risk: the virus can reach the fetus and may cause miscarriage, stillbirth or birth defects.
The virus has been reported in some African countries and in Japan. It was first detected in Europe during the summer of this year, and the data cited in the report indicate that it has been found in livestock in 14 European countries. Earlier this year, researchers also identified two recently detected genetic lineages, named SHAV-EU1 and SHAV-EU2. Genetic tests found traces of the first lineage, SHAV-EU1, in samples of fluid surrounding the brain and spinal cord, as well as in urine, saliva and other samples from the man who died.
Tracking these genetic lineages is about more than sorting the virus into categories. Comparing viral genetic material from animals, insects and human samples could help scientists understand how the virus spreads and how it has changed. But finding a particular genetic lineage in a human sample cannot, by itself, reveal where or when the person was exposed, or prove that the virus is spreading continuously between people. Answering those questions will require evidence from more than one case.
What do we know about the chances of it spreading?
Shamonda belongs to the Simbu group and the genus Orthobunyavirus. Both include Oropouche virus, also known as sloth fever. Oropouche was linked to about 9.4 million human infections in Latin America and the Caribbean between 1960 and 2025. That example shows that some related viruses can cause a substantial burden of human disease. It does not mean Shamonda will follow the same path: sharing a classification does not mean viruses have the same ability to infect people or spread among them.
Virologist Natasha Tillstone-Lunell, of Indiana University School of Medicine, says such comparisons are useful but should be treated with caution. She points out that Schmallenberg virus, which is closely related to Shamonda, is widespread in livestock but is not known to infect people. Based on the evidence available, she considers the risk of human Shamonda infections potentially limited as well. Tillstone-Lunell was not involved in preparing the new report.
But the apparent rarity of infections does not settle the question, particularly when human disease surveillance is incomplete. Some cases of encephalitis in people with weakened immune systems may go unexplained, and patients may not be tested for unexpected viruses. Martin Beer, a veterinarian and virologist at the Friedrich-Loeffler-Institut in Germany, notes that unexplained brain inflammation has been seen in immunocompromised people infected with other viruses from the genus Orthobunyavirus, including Jamestown Canyon virus and Cache Valley virus.
Insects and weather shape the transmission cycle
Viruses in the Simbu group are transmitted mainly by biting midges. Beer explains that these insects can spread infection quickly, particularly in summer and autumn, when conditions are favorable for their activity. In winter, transmission slows because biting midge populations become very small. Temperatures below about 12 degrees Celsius also do not allow the virus to multiply efficiently, he says.
This seasonal pattern matters when scientists try to understand how viruses appear in new areas and decide when surveillance should be most focused. But it does not, by itself, tell us how much risk the virus poses to people. The presence of both the virus and its carrier in the same area does not automatically mean people will be infected. Nor does one identified case show that insects transmit the virus to humans repeatedly. A spokesperson for the European Centre for Disease Prevention and Control says more clarity is needed about how the virus is transmitted and what role insect carriers play in human infections.
Why surveillance matters now
A scientific priority is to determine whether the case in France was a rare exception or whether milder infections have gone undiagnosed. Destra suggests testing stored samples from immunocompromised people in France for traces of the virus that may reveal infections missed at the time. This approach could help estimate how often people have been exposed, but it depends on having suitable samples and tests that can distinguish Shamonda from closely related viruses.
Another important step is to expand surveillance in animals—including livestock and fetuses from animals that miscarried—and to monitor the insects that carry the virus. Testing animals alone may not reveal every stage of the transmission cycle, while detecting the virus in biting midges could help researchers map where it is present and when the insects are active. Genetic analysis of human samples could also show whether viruses found in people are related to those detected in animals, or whether any changes have emerged that deserve closer attention.
Tillstone-Lunell also calls for more information about antibodies to Shamonda in people. Antibodies can indicate that someone was exposed to the virus in the past, even if the illness was never identified as Shamonda infection. If evidence shows that people have been exposed before, it could help distinguish between an uncommon infection that usually causes no clear symptoms and a risk of more serious illness concentrated in certain groups, such as people with weakened immune systems. There are currently no vaccines to protect animals or people against Shamonda infection.
These measures are tools for monitoring and understanding the virus, not evidence that a human outbreak is imminent. The current scientific assessment finds no sign that it is spreading more widely among people, but researchers cannot rule out undetected infections or a change in the level of risk as surveillance expands. The distinction between a possibility and an established fact matters: Shamonda is known to infect animals, while what it does in people is still based on a single documented case.
The Bottom Line
The death of a 61-year-old man in France revealed the first known human infection with Shamonda virus, after decades in which the virus was associated with animals and insect carriers. His illness involved fatal brain inflammation, but there is currently no evidence of person-to-person spread or a large outbreak. Pinpointing the source of his infection, testing older samples from people with weakened immune systems, and monitoring insects, animals and viral genetic changes will help show whether this was truly an isolated event—or an early sign of a risk that had gone unnoticed.